NCT00068172View on ClinicalTrials.gov

Study of PI-88 in Patients With Advanced Melanoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

July 31, 2001

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Melanoma
Interventions
DRUG

PI-88

Trial Locations (1)

80010-05801

University of Colorado Health Sciences Center, Aurora

Sponsors
All Listed Sponsors
collaborator

Medigen Biotechnology Corporation

INDUSTRY

lead

Cellxpert Biotechnology Corp.

INDUSTRY